Pediatrix Medical Group Inc’s filing revealed that its Chief Executive Officer Swift James D unloaded Company’s shares for reported $55219.0 on Dec 14 ’23. In the deal valued at $9.58 per share,5,764 shares were sold. As a result of this transaction, Swift James D now holds 90,874 shares worth roughly $0.81 million.
Then, Moore Mary Ann E sold 1,150 shares, generating $11,063 in total proceeds. Upon selling the shares at $9.62, the EVP, General Counsel & Sec now owns 15,730 shares.
Before that, Moore Mary Ann E sold 970 shares. Pediatrix Medical Group Inc shares valued at $9,331 were divested by the EVP, General Counsel & Sec at a price of $9.62 per share. As a result of the transaction, Moore Mary Ann E now holds 81,385 shares, worth roughly $0.73 million.
SVB Leerink initiated its Pediatrix Medical Group Inc [MD] rating to a Mkt perform in a research note published on September 27, 2021; the price target was $29. Deutsche Bank also remained covering MD and has decreased its forecast on October 19, 2020 with a “Sell” recommendation from previously “Hold” rating. Citigroup revised its rating on January 03, 2020. It rated MD as “a Neutral” which previously was an “a Buy”.
Price Performance Review of MD
On Tuesday, Pediatrix Medical Group Inc [NYSE:MD] saw its stock fall -2.73% to $8.92. Over the last five days, the stock has lost -6.60%. Pediatrix Medical Group Inc shares have fallen nearly -4.09% since the year began. Nevertheless, the stocks have fallen -38.99% over the past one year. While a 52-week high of $15.06 was reached on 03/28/24, a 52-week low of $7.70 was recorded on 02/20/24. SMA at 50 days reached $9.19, while 200 days put it at $11.05. A total of 0.47 million shares were traded, compared to the trading of 0.46 million shares in the previous session.
Levels Of Support And Resistance For MD Stock
The 24-hour chart illustrates a support level at 8.83, which if violated will result in even more drops to 8.74. On the upside, there is a resistance level at 9.09. A further resistance level may holdings at 9.26. The Relative Strength Index (RSI) on the 14-day chart is 39.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.21%. Stochastics %K at 7.30% indicates the stock is a buying.
